Search results
Author(s):
Mohammed Sallam
,
Hossameldin Hassan
,
Derek Connolly
,
et al
Added:
1 year ago
Author(s):
María Iglesias Alonso
,
Jose Manuel Iglesias Sanmartin
Added:
1 month ago
Added:
1 month ago
Source:
Radcliffe CVRM
Recent US guidelines have controversially recommended lowering the low-density lipoprotein cholesterol (LDL-C) target to <55 mg/dL for patients with established atherosclerotic cardiovascular disease (ASCVD).¹˒² The Ez-PAVE trial is the first randomised study to directly compare this intensive target with a conventional target of <70 mg/dL. The findings were published in The New England…
View more
Author(s):
Kausik Ray
,
Upendra Kaul
,
Srinivasa Rao
,
et al
Added:
5 months ago
Lipid-lowering Therapies and Lp(a)
Author(s):
Stephen Nicholls
,
Adam J Nelson
Added:
3 weeks ago
Review Article
Meta-analysis and Meta-regression Applicability
Author(s):
Alberto Cordero
,
Carlos G Santos-Gallego
,
Armando Oterino
,
et al
Added:
8 months ago
Review Article